Activation enhances glucose-dependent insulin release, inhibits glucagon secretion, and slows gastric emptyingmechanisms widely studied in metabolic research. 2
Clinical Evidence: Visceral Fat Reduction on GLP-1 Therapy The LEADER trial (2016) and subsequent cardiovascular outcomes studies documented that GLP-1 receptor agonists reduce visceral adipose tissue volume by 1525% in patients achieving 1015% total body weight loss
Because she didnt experience any digestive issues with this supplement, she gave it a rating of 5 out of 5 for side effects
Some inherent mechanisms of the tumor itself help tumor cells escape the surveillance and killing effects of the immune system, so tumor immune escape is also one of the bottlenecks to improving the current therapeutic effect on tumors (138)
If side effects persist beyond 12 weeks, inform your PlexusDx providerthey may adjust timing, recommend hydration changes, or suggest a slower dose escalation schedule
doi: 10.1016/j.xkme.2020.10.008